Zobrazeno 1 - 10
of 58
pro vyhledávání: '"Alexander, Wurzer"'
Autor:
Alexander Wurzer, Francesco De Rose, Sebastian Fischer, Markus Schwaiger, Wolfgang Weber, Stephan Nekolla, Hans-Jürgen Wester, Matthias Eiber, Calogero D’Alessandria
Publikováno v:
EJNMMI Radiopharmacy and Chemistry, Vol 9, Iss 1, Pp 1-14 (2024)
Abstract Background Radiohybrid PSMA-targeted ligands (rhPSMA) have been introduced as a novel platform for theranostic applications. Among a variety of rhPSMA-ligands developed for radioligand therapy, two stereoisomers [177Lu]Lu-rhPSMA-10.1 and -10
Externí odkaz:
https://doaj.org/article/ccf30793e8eb4523920eb4bb36e6f0e6
Autor:
Karina Knorr, So Won Oh, Markus Krönke, Alexander Wurzer, Calogero D’Alessandria, Michael Herz, Wolfgang Weber, Hans-Jürgen Wester, Matthias Eiber, Nahid Yusufi, Stephan Nekolla
Publikováno v:
EJNMMI Research, Vol 12, Iss 1, Pp 1-8 (2022)
Abstract Background Radiohybrid prostate-specific membrane antigen (rhPSMA) ligands such as 18F-rhPSMA-7 are a new class of theranostic agents in clinical development for prostate cancer. We compared preclinical dosimetry and human biodistribution of
Externí odkaz:
https://doaj.org/article/6d6f3110cc4240e4a9a58c67269248bc
Autor:
Alexander Wurzer, Daniel Di Carlo, Michael Herz, Antonia Richter, Stephanie Robu, Ralf Schirrmacher, Alba Mascarin, Wolfgang Weber, Matthias Eiber, Markus Schwaiger, Hans-Juergen Wester
Publikováno v:
EJNMMI Radiopharmacy and Chemistry, Vol 6, Iss 1, Pp 1-15 (2021)
Abstract Introduction The radiohybrid (rh) prostate-specific membrane antigen (PSMA)-targeted ligand [18F]Ga-rhPSMA-7 has previously been clinically assessed and demonstrated promising results for PET-imaging of prostate cancer. The ligand is present
Externí odkaz:
https://doaj.org/article/8f0946dcb5d249ac872b366eaca886a9
Autor:
Alexander Wurzer, Mara Parzinger, Matthias Konrad, Roswitha Beck, Thomas Günther, Veronika Felber, Stefanie Färber, Daniel Di Carlo, Hans-Jürgen Wester
Publikováno v:
EJNMMI Research, Vol 10, Iss 1, Pp 1-10 (2020)
Abstract Introduction Radiohybrid (rh) ligands, a novel class of prostate-specific membrane antigen (PSMA)-targeted radiopharmaceuticals, can be labeled either with [18F]fluorine via isotopic exchange or with radiometals (such as [68Ga]Gallium, [177L
Externí odkaz:
https://doaj.org/article/7ac00bd0ff594505bde0da78cf92916d
Publikováno v:
Pharmaceuticals, Vol 15, Iss 9, p 1161 (2022)
A meticulously adjusted pharmacokinetic profile and especially fine-tuned blood clearance kinetics are key characteristics of therapeutic radiopharmaceuticals. We, therefore, aimed to develop a method that allowed the estimation of blood clearance ki
Externí odkaz:
https://doaj.org/article/247c56d7fa3e49c8a3b36aa0bae4380f
Autor:
Stefanie Felicitas Färber, Alexander Wurzer, Florian Reichart, Roswitha Beck, Horst Kessler, Hans-Jürgen Wester, Johannes Notni
Publikováno v:
ACS Omega, Vol 3, Iss 2, Pp 2428-2436 (2018)
Externí odkaz:
https://doaj.org/article/c6600f267dd4423f826544713a9d9e9d
Publikováno v:
Angewandte Nuklearmedizin. 45:167-188
ZusammenfassungDie wachsende Zahl potenzieller Radioisotope und die steigende Nachfrage nach Radiopharmazeutika (RP) für Bildgebung- und Therapiezwecke haben dazu geführt, dass ihre biomedizinische Anwendung im modernen Gesundheitswesen immer mehr
Autor:
Markus Kroenke, Lilit Schweiger, Thomas Horn, Bernhard Haller, Kristina Schwamborn, Alexander Wurzer, Tobias Maurer, Hans-Jürgen Wester, Matthias Eiber, Isabel Rauscher
Publikováno v:
Journal of Nuclear Medicine. 63:1809-1814
Autor:
Alexander Wurzer, Jan-Philip Kunert, Sebastian Fischer, Veronika Felber, Roswitha Beck, Francesco de Rose, Calogero D’Alessandria, Wolfgang Weber, Hans-Jürgen Wester
Publikováno v:
Journal of Nuclear Medicine. 63:1489-1495
Autor:
Thomas Langbein, Hui Wang, Isabel Rauscher, Markus Kroenke, Karina Knorr, Alexander Wurzer, Kristina Schwamborn, Tobias Maurer, Thomas Horn, Bernhard Haller, Hans-Jürgen Wester, Matthias Eiber
Publikováno v:
Journal of Nuclear Medicine. 63:1334-1342